MetLife Investment Advisors »

Akero Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 39k 28.69
2024-06-30 $921k 39k 23.46
2023-12-31 $630k 27k 23.35
2023-09-30 $1.4M 27k 50.58
2023-06-30 $1.1M 24k 46.69
2023-03-31 $699k 18k 38.26
2022-12-31 $1.0M 18k 54.80
2022-09-30 $531k 16k 34.05
2022-06-30 $147k 16k 9.45
2022-03-31 $221k 16k 14.18
2021-12-31 $208k 9.8k 21.16
2021-09-30 $220k 9.8k 22.35
2021-06-30 $244k 9.8k 24.82
2021-03-31 $162k 5.6k 28.99
2020-12-31 $144k 5.6k 25.80
2020-09-30 $172k 5.6k 30.79
2020-06-30 $139k 5.6k 24.92